In Genome Research this week: queen bee chromatin profiles, quantitative trait loci and allele-specific expression in wild house mice, and more.
The court upheld a judgement of no interference-in-fact from the Patent Trial and Appeal Board, leaving the Broad in control of key CRISPR IP.
In Science this week: common metastatic driver genes, inhibitors of CRISPR, and more.
These Cas inhibitors — published in two studies — inhibit the activity of several Type V-A and Type I-C CRISPR systems, including several Cas12a orthologs.
The firm said it will use the funds to build its IP portfolio, expand its team, and develop an infrastructure for partners to build on its CRISPR platform.
In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.
In Nature this week: novel soil-dwelling bacteria may be source of molecules with biomedical potential, and more.
Three CRISPR researchers are to receive the Kavli Prize in nanoscience, according to the Associated Press.
Inder Verma had been on leave from PNAS since December after three female scientists at the Salk Institute filed a lawsuit claiming gender discrimination.
Reuters reports that the panel hearing the CRISPR gene editing patent case appears split.
This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.
The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.
Researchers find that people's genetics influence their success at university, but that it is not the only factor.
In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.